Supply Chain

Belgium-based Sasmar Pharmaceuticals recently acquired Aquatrove Biosciences, a Chicago-based biotech focused on the reproductive health and fertility market.

Amgen, Sanofi and Regeneron would need to lower the list price of their cholesterol-lowering drugs by more than two-thirds to ensure the treatments are cost-effective in the U.S., according to a new study published in JAMA Tuesday.

Narcan nasal spray — the first Food and Drug Administration-approved nasal spray version of naloxone, a medication that reverses the side effects of an opioid overdose — has been made available at 96 Kroger locations across the state of Kentucky,…

In June, the CDC recommended against using AstraZeneca's nasal flu vaccine, FluMist, citing a lack of evidence regarding the vaccine's efficacy. Now, results from a new Canadian study contradict this decision and point to the vaccine's effectiveness.

Researchers examined the ethical implications surrounding the close-knit relationships physicians and medical device representative develop in the operating room in a new study published in the journal Plos One.

The Food and Drug Administration on Monday launched an updated web-based version of the "Orange Book" — the agency's publication that lists all drug approvals on the basis of safety and efficacy.

Bavarian Nordic, a Danish biotech company, entered into a drug supply agreement with New York-based Bristol-Myers Squibb.

Walgreens recently added secure medication disposal kiosks to 45 stores throughout Illinois, reports the Chicago Tribune.

After experiencing statewide blood shortages this spring, Anchorage-based Blood Bank of Alaska experienced a surplus of donations. Now the bank is shipping extra blood to California, according to the Alaska Dispatch News.

Economic pressures to control the rising cost of medical devices has intensified efforts by providers to make better informed purchasing decisions and elicited demand for better "proof" of product superiority from manufacturers.